Softwr

Healthcare · head to head

Paige vs Updox

Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite
Updox logo

Updox

Healthcare

Healthcare communications platform for eFax, telehealth and patient reminders

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.; Updox no specific dollar amounts listed on pricing page
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Paige and Updox actually diverge.

Attributes where Paige and Updox differ
AttributePaigeUpdox
PlatformsWeb, Cloud, On-premiseWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

Only in Updox

Nothing recorded that Paige does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Updox
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Updox
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Updox
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Updox

Updox

  • Healthcare communication and patient engagementnot Paige
  • Medical practice fax, telehealth, and SMS messagingnot Paige
  • Charge capture and medical billing workflowsnot Paige
  • Multi-location healthcare systemsnot Paige

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Updox

  • No specific dollar amounts listed on pricing page
  • Actual costs require contacting sales team or scheduling a demo
  • Standard and Enterprise tier limits shown but no pricing transparency

Pricing, plan by plan

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Updox

On request

No published plan breakdown. See the Updox review.

Which should you pick?

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Choose Updox if

Nothing in the data separates Updox from Paige on the points above - pick on price and on how each one feels to use.

Updox review

Questions people ask

Is Paige or Updox better?
Neither clearly leads. Paige starts at On request and Updox at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Paige or Updox?
Paige starts at On request and Updox at On request.
Does Paige or Updox run on more platforms?
Paige runs on Web, Cloud, On-premise. Updox runs on Web.
What is Paige best used for?
Paige is most often used for a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable, a pathology department already digitised that wants a documented safety net against missed small foci of cancer, a hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reporting, a pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variability. Of those, a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable and a pathology department already digitised that wants a documented safety net against missed small foci of cancer are not what Updox is typically brought in for.
What can Paige do that Updox cannot?
Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications.

Answered from the vendors’ own pages

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Updox: How much does Updox cost?

Updox pricing is not published on the pricing page. The vendor offers customizable packages and directs inquiries to schedule a demo or contact the sales team for personalized pricing based on practice size and tool requirements.

Source
Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Updox: What is Updox's pricing model?

Updox uses a usage-based pricing model with customizable packages. Costs are tailored based on the tools selected (fax pages, telehealth sessions, patient reminders, text messages, broadcast messages) and can scale with practice benchmark data.

Source
Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Updox: What limits are included in Updox's Standard tier?

Updox Standard tier includes up to 1,000 fax pages, 75 telehealth sessions, reminders for 500 appointments, 500 text messages, and 500 broadcast messages monthly, with higher limits available in Enterprise tier.

Source
Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Share

Related pages

More on Paige

More on Updox

Keep looking

Other head to heads